<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li K</submitter><funding>Sail Plan" from Beijing Hospital Authority</funding><funding>Beijing Key Laboratory</funding><funding>Beijing You'An Hospital</funding><funding>Beijing Municipal Science &amp;amp; Technology Commission</funding><funding>Capital's Funds of Health Improvement and Research</funding><funding>National Key Research and Development Project</funding><pagination>8680</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9782793</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>27(24)</volume><pubmed_abstract>Neuroblast differentiation-associated protein AHNAK, a large structural scaffold protein, remains mysterious in biological processes. AHNAK plays a suppressive or progressive role in different types of cancers. To investigate the role of the AHNAK in hepatocellular carcinoma (HCC), cell viability assays were performed to determine the cell proliferation of the stable AHNAK-knockdown HepG2 cell line; co-immunoprecipitation (Co-IP) and liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) were performed on HCC and matched paracancerous (MPC) tissues. The Metascape platform was used for enrichment analyses; the "ComplexHeatmap" package was applied for cluster analyses and visualization. Co-IP, Western botting and immunofluorescence double staining were performed to assess the</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pubmed_title>AHNAK Contributes to Hepatocellular Carcinoma Growth by Interacting with IGF-1R.</pubmed_title><pmcid>PMC9782793</pmcid><funding_grant_id>Z171100001017078</funding_grant_id><funding_grant_id>CFH2020-1-2182</funding_grant_id><funding_grant_id>BJYAHKF2021003,YNKTQN2021007</funding_grant_id><funding_grant_id>XMLX201711</funding_grant_id><funding_grant_id>2020YFE0202400</funding_grant_id><funding_grant_id>BZ0373</funding_grant_id><pubmed_authors>Sun L</pubmed_authors><pubmed_authors>Song K</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Tian Y</pubmed_authors><pubmed_authors>Li A</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Li K</pubmed_authors><pubmed_authors>Hou Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>AHNAK Contributes to Hepatocellular Carcinoma Growth by Interacting with IGF-1R.</name><description>Neuroblast differentiation-associated protein AHNAK, a large structural scaffold protein, remains mysterious in biological processes. AHNAK plays a suppressive or progressive role in different types of cancers. To investigate the role of the AHNAK in hepatocellular carcinoma (HCC), cell viability assays were performed to determine the cell proliferation of the stable AHNAK-knockdown HepG2 cell line; co-immunoprecipitation (Co-IP) and liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) were performed on HCC and matched paracancerous (MPC) tissues. The Metascape platform was used for enrichment analyses; the "ComplexHeatmap" package was applied for cluster analyses and visualization. Co-IP, Western botting and immunofluorescence double staining were performed to assess the</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-04T07:59:04.071Z</modification><creation>2025-04-04T07:59:04.071Z</creation></dates><accession>S-EPMC9782793</accession><cross_references><pubmed>36557813</pubmed><doi>10.3390/molecules27248680</doi></cross_references></HashMap>